Luohai Chen

复旦大学

H指数:11

被引数:362

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression

通过重新激活MEN1表达抑制SIRT7克服胰腺神经内分泌肿瘤的放射抗性

Advanced Science

IF14.1

2026-04-130

Telotristat ethyl affects tumour-fibroblast crosstalk in small intestinal neuroendocrine tumours

Telotristat ethyl影响小肠神经内分泌肿瘤中的肿瘤-成纤维细胞串扰

Journal of Neuroendocrinology

IF4.1

2025-09-250

OAAI

Trans-Arterial Embolization for Liver Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Response Indicates Survival Benefit?

经动脉栓塞术治疗胃肠胰神经内分泌肿瘤肝转移：反应是否预示生存获益？

CANCERS

IF4.4

2025-01-190

Single-cell transcriptomic landscape indicates the potential role of immunotherapy in metastatic pancreatic angiosarcoma

单细胞转录组景观表明免疫疗法在转移性胰腺血管肉瘤中的潜在作用

GASTROENTEROLOGY REPORT

IF4.2

2025-01-010

OAAI

Efficacy, safety, and prognostic factors of capecitabine plus temozolomide regimen in patients with atypical thymic carcinoids

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-11-270

OAAI

A comprehensive review and update on acute severe lower gastrointestinal bleeding in Crohn's disease: a management algorithm

克罗恩病急性严重下消化道出血的全面综述与更新：诊疗流程图

GASTROENTEROLOGY REPORT

IF4.2

2024-11-060

OAAI

Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors

NEUROENDOCRINOLOGY

IF2.8

2023-12-071

Safety and Efficacy of 177Lu-DOTATATE in Neuroendocrine Tumor Patients With Extensive Bone Disease

CLINICAL NUCLEAR MEDICINE

IF9.6

2023-05-111

Single centre retrospective review of outcome of 177Lu-DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors

JOURNAL OF NEUROENDOCRINOLOGY

IF4.1

2022-11-185

PRE

Special issue the advance of solid tumor research in China: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors

中国实体瘤研究进展: 胰腺神经内分泌肿瘤患者ct预测舒尼替尼疗效

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2022-10-0710

PRE

The role of quantitative tumor burden based on [68Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-10-017

PRE

Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-202

OAAI

Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms

Bcl-2和Noxa是胃肠胰神经内分泌肿瘤患者的潜在预后指标

ENDOCRINE

IF2.9

2022-07-274

PRE

Safety of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2022-02-245

Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate

ENDOCRINE-RELATED CANCER

IF4.6

2022-02-016

PRE

Genetic Characteristics of Colorectal Neuroendocrine Carcinoma: More Similar to Colorectal Adenocarcinoma

CLINICAL COLORECTAL CANCER

IF3.2

2021-06-0127

PRE

177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-04-096

PREAI

Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors

ENDOSCOPY

IF12.8

2020-12-1615

PREAI

Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms

胃肠胰神经内分泌肿瘤中的髓源性抑制细胞

ENDOCRINE

IF2.9

2020-10-036

PREAI

Quantitative Pretreatment CT Parameters as Predictors of Tumor Response of Neuroendocrine Tumor Liver Metastasis to Transcatheter Arterial Bland Embolization

NEUROENDOCRINOLOGY

IF2.8

2019-10-2214

PREAI

Luohai Chen

个人简介

教育背景

工作经历

荣誉奖项

研究方向